Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Neoplasms 7 Anxiety Disorders 6 Depression 3 Ovarian Neoplasms 2 Chronic Pain 2 Vomiting 1 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Tendinopathy 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sarcoma 1 Radiculopathy 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Pathophobia 1 Pain, Postoperative 1 Pain 1 Nociceptive Pain 1 Neuralgia, Postherpetic 1 Neuralgia 1 Nausea 1 Myocarditis 1 Musculoskeletal Pain 1 Melanoma 1 Medication Adherence 1 Lung Diseases, Interstitial 1 Leukemia, Myeloid, Acute 1 Hot Flashes 1

Interventions

Bevacizumab 17 Capecitabine 13 Cetuximab 10 Oxaliplatin 8 Irinotecan 8 Fluorouracil 7 Panitumumab 5 Leucovorin 4 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Ipilimumab 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Folfox protocol 2 Drug Therapy 2 spartalizumab 1 pembrolizumab 1 irinotecan sucrosofate 1 glucopyranosyl lipid-A 1 folfirinox 1 camrelizumab 1 balstilimab 1 anisodamine 1 aflibercept 1 XELOX 1 Vemurafenib 1 Tyrosine Kinase Inhibitors 1 Transurethral Resection of Prostate 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Cancer Metastatic × Hypnosis × Clear all

NCT04999306 2025-02-13

COLOFIGHT

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡